HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Fukuda Selected Research

L-Selectin

6/2015Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses.
4/2012Sulfated glycans control lymphocyte homing.
5/2011Prominent expression of sialyl Lewis X-capped core 2-branched O-glycans on high endothelial venule-like vessels in gastric MALT lymphoma.
12/2010Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.
5/2009GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis.
5/2009Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.
7/2007Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis.
1/2006Cell type-specific roles of carbohydrates in tumor metastasis.
12/2005Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.
1/2004Core 2 branching beta1,6-N-acetylglucosaminyltransferase and high endothelial venule-restricted sulfotransferase collaboratively control lymphocyte homing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Fukuda Research Topics

Disease

57Neoplasms (Cancer)
12/2021 - 01/2002
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 12/2004
16Lung Neoplasms (Lung Cancer)
01/2021 - 01/2006
15Neoplasm Metastasis (Metastasis)
12/2021 - 01/2002
15Infections
02/2016 - 11/2003
13Prostatic Neoplasms (Prostate Cancer)
03/2016 - 12/2003
10Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 11/2004
8Carcinoma (Carcinomatosis)
01/2021 - 10/2002
7Adenocarcinoma
10/2019 - 10/2004
7Inflammation (Inflammations)
10/2019 - 07/2002
6Febrile Neutropenia
09/2021 - 06/2008
6Pneumonia (Pneumonitis)
01/2021 - 02/2005
5Gastritis
10/2019 - 02/2003
4Adenocarcinoma of Lung
01/2021 - 10/2014
4Neutropenia
11/2019 - 06/2008
4Stomach Neoplasms (Stomach Cancer)
10/2019 - 02/2003
4Melanoma (Melanoma, Malignant)
11/2018 - 10/2002
3Testicular Neoplasms (Testicular Cancer)
08/2021 - 10/2014
3Experimental Melanoma
11/2020 - 08/2002
3Leukopenia
11/2019 - 01/2017
3Breast Neoplasms (Breast Cancer)
03/2016 - 11/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 01/2002
3Colitis
12/2012 - 01/2010
3Tuberculosis (Tuberculoses)
01/2007 - 02/2005
2Interstitial Lung Diseases (Interstitial Lung Disease)
04/2020 - 01/2006
2Fibrosis (Cirrhosis)
04/2020 - 11/2009
2Thymoma (Thymic Carcinoma)
01/2020 - 05/2007
2Carcinogenesis
10/2019 - 01/2010
2Rheumatoid Arthritis
10/2018 - 02/2013
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2017 - 06/2012
2Fever (Fevers)
02/2016 - 08/2005
2Contact Dermatitis (Eczema, Contact)
06/2015 - 12/2010
2Virus Diseases (Viral Diseases)
03/2015 - 01/2013
2Disease Progression
12/2013 - 01/2006

Drug/Important Bio-Agent (IBA)

28Polysaccharides (Glycans)IBA
06/2017 - 12/2003
16CarbohydratesIBA
03/2016 - 08/2002
10Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 12/2004
10L-SelectinIBA
06/2015 - 01/2004
10LigandsIBA
02/2013 - 01/2002
9amrubicinIBA
01/2022 - 06/2009
9Pharmaceutical PreparationsIBA
04/2020 - 05/2005
9Proteins (Proteins, Gene)FDA Link
01/2013 - 02/2003
8Sialyl Lewis X AntigenIBA
06/2015 - 08/2002
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2007
6Carboplatin (JM8)FDA LinkGeneric
01/2017 - 12/2004
6Anti-Bacterial Agents (Antibiotics)IBA
02/2016 - 08/2004
6Laminin (Merosin)IBA
03/2012 - 10/2005
5osimertinibIBA
12/2021 - 01/2019
5AntigensIBA
08/2021 - 10/2008
5ErbB Receptors (EGF Receptor)IBA
06/2020 - 02/2011
5Biomarkers (Surrogate Marker)IBA
12/2019 - 02/2006
5EnzymesIBA
12/2019 - 10/2006
5Messenger RNA (mRNA)IBA
01/2019 - 01/2002
5Peptides (Polypeptides)IBA
06/2017 - 07/2002
5polysialic acidIBA
01/2013 - 12/2003
5OligosaccharidesIBA
02/2012 - 10/2002
4AntibodiesIBA
08/2021 - 08/2011
4Pemetrexed (MTA)FDA Link
01/2021 - 01/2017
4PlatinumIBA
01/2021 - 09/2012
4Gefitinib (Iressa)FDA Link
08/2016 - 11/2006
4IntegrinsIBA
03/2016 - 01/2010
4ChemokinesIBA
03/2015 - 03/2007
4MucinsIBA
03/2012 - 01/2006
4L-selectin counter-receptorsIBA
05/2009 - 12/2004
3Tyrosine Kinase InhibitorsIBA
06/2020 - 02/2011
3poly-N-acetyllactosamineIBA
06/2017 - 06/2012
3Galectin 3 (LGALS3)IBA
06/2017 - 01/2002
3Prostate-Specific Antigen (Semenogelase)IBA
03/2016 - 08/2004
3GemcitabineFDA Link
02/2016 - 05/2007
3Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2015 - 11/2005
3Indicators and Reagents (Reagents)IBA
01/2015 - 12/2003
3EpitopesIBA
06/2014 - 01/2012
3Monoclonal AntibodiesIBA
06/2014 - 10/2004
3GlycosyltransferasesIBA
06/2014 - 02/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013 - 06/2012
3Gastric MucinsIBA
03/2012 - 08/2004
3Dystroglycans (Dystroglycan)IBA
08/2011 - 07/2009
3SelectinsIBA
12/2003 - 07/2002
2Etoposide (VP 16)FDA LinkGeneric
01/2022 - 11/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2021 - 02/2016
2pembrolizumabIBA
01/2021 - 10/2018
2Bevacizumab (Avastin)FDA Link
01/2020 - 01/2019
2Docetaxel (Taxotere)FDA Link
01/2020 - 02/2016
2ImmunosorbentsIBA
12/2019 - 12/2006
2SulfotransferasesIBA
10/2019 - 02/2010
2sulfomucinIBA
10/2019 - 02/2010
2nedaplatinIBA
01/2019 - 01/2014
2NivolumabIBA
11/2018 - 01/2018
2SteroidsIBA
11/2018 - 06/2008
2Immune Checkpoint InhibitorsIBA
10/2018 - 01/2018
2Toll-Like Receptor 3IBA
03/2015 - 01/2013

Therapy/Procedure

15Therapeutics
08/2021 - 10/2004
12Drug Therapy (Chemotherapy)
09/2021 - 05/2005
11Radiotherapy
01/2022 - 05/2007
3Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 09/2012
3Immunotherapy
10/2020 - 10/2014
2Aftercare (After-Treatment)
06/2020 - 12/2006
2Traction
04/2020 - 11/2009
2Intravenous Injections
04/2019 - 01/2006
2Chemoradiotherapy
11/2017 - 01/2006